Portfolio company
OCUTEC
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops polyethylene glycol-based soft contact lenses using proprietary polymer chemistry for the global vision correction and eye care markets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Tangible Science
This company develops coatings and care solutions for contact lenses to improve comfort for patients and practitioners.
EyeYon
This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.
Glakolens
This company develops sensor-embedded contact lenses that provide continuous intraocular pressure monitoring for patients with glaucoma and ocular hypertension.
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
Cornea Project
This company develops point-of-care diagnostic devices and molecular biomarker analysis technologies for ophthalmologists to detect corneal diseases like keratoconus and dry eye syndrome.
Ocuwell
This company develops portable corneal topography systems and diagnostic software for clinicians and opticians to improve global access to eye care.
Azalea Vision
This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.
StemSight
This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.
